ADAP Adaptimmune Therapeutics
- 1.210
- +0.020+1.68%
- 1.239
- +0.029+2.38%
Adaptimmune Therapeutics News
Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 1, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell
Adaptimmune Therapeutics Plc (NASDAQ:ADAP) Not Doing Enough For Some Investors As Its Shares Slump 30%
The Adaptimmune Therapeutics plc (NASDAQ:ADAP) share price has softened a substantial 30% over the previous 30 days, handing back much of the gains the stock has made lately.
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
European equities traded in the US as American depositary receipts jumped Tuesday morning, advancing 1.31% to 1,362.51 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
Garry Menzel Joins GHO Capital as Operating Partner
Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR2 Therapeutics with significant investment and operating experience to support deal origination and provide best in class services to pioneering
Leerink Partners Sticks to Its Hold Rating for Adaptimmune Therapeutics (ADAP)
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMobile-health Network (NASDAQ:MNDR) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. Galera Therapeutics (NASDAQ:GRTX) stock in
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Adaptimmune Therapeutics (ADAP)
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
European equities traded in the US as American depositary receipts were treading water in Thursday morning session, nudging 0.006% higher to 1,330.06 on the S&P Europe Select ADR Index. From continent
Maintaining Buy Rating on Adaptimmune Therapeutics Post-Genentech Collaboration Termination
Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP) and Immunic (IMUX)
Hedge Funds Owners May Take Dramatic Actions as Adaptimmune Therapeutics Plc's (NASDAQ:ADAP) Recent 15% Drop Adds to One-year Losses
Key Insights Significantly high institutional ownership implies Adaptimmune Therapeutics' stock price is sensitive to their trading actions The top 4 shareholders own 56% of the company Recent sa
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
European equities traded in the US as American depositary receipts were lower Friday morning, falling 0.66% to 1,356.48 on the S&P Europe Select ADR Index. The index is poised to close the week down n
Adaptimmune Therapeutics Says Unit Gets Termination Notice for Strategic Collaboration With Genentech
Adaptimmune Therapeutics plc (ADAP) said Friday that its Adaptimmune Ltd. unit has received a notice of termination of the strategic collaboration and license agreement with Genentech and F. Hoffman-L
Adaptimmune Slips as Roche Strategic Collaboration Ends
Strategic Collaboration Between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
Company remains focused on launching afami-cel later this year with a PDUFA date of August 4th and developing its broader sarcoma franchiseUpdate on afami-cel launch plans to be provided at the April
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending lower during Wednesday morning's session, falling 0.9% to 1,365.87 on the S&P Europe Select ADR Index. From continental
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
European equities traded in the US as American depositary receipts were trending modestly higher Friday morning, rising 0.27% to 1,369.92 on the S&P Europe Select ADR Index. However, the gain isn't en
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
European equities traded in the US as American depositary receipts fell Tuesday, dropping 0.79% to 1,362.68 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by semicon
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher
European equities traded in the US as American depositary receipts kicked off the week slightly higher in late Monday morning trading, rising 0.11% to 1,375.19 on the S&P Europe Select ADR Index. From
Analysis
Price Target
No Data
